Skip to main content
. 2010 Dec 22;19(4):479–484. doi: 10.1038/ejhg.2010.197

Table 2. Meta-analysis of association with SLE for the Swedish and US cohorts.

    Swedena USb Meta-analysisc
Gene SNP Pd OR (95% CI) Pd OR (95% CI)e Risk allele P Corrected Pf OR (95% CI)e
IKBKE rs1539243 0.031 1.19 (1.02–1.39) 0.0028 1.20 (1.07–1.35) C 0.00026 0.0054 1.19 (1.09–1.31)
IKBKE rs17433930 0.013 1.33 (1.06–1.67) 0.0021 1.33 (1.11–1.58) A 0.00010 0.0022 1.33 (1.16–1.53)
TANK rs3754974 0.0087 1.44 (1.09–1.89) 0.98 0.99 (0.80–1.22) NA 0.22 1.0 1.13 (0.96–1.34)
TANK rs1267075 0.75 1.02 (0.88–1.19) 0.87 0.99 (0.89–1.11) NA 0.99 1.0 1.00 (0.92–1.10)
STAT1 rs2030171 1.2E−05 1.31 (1.16–1.49) 0.018 1.11 (1.02–1.21) A 3.3E−05 0.00069 1.17 (1.09–1.26)
STAT1 rs16833172 0.015 1.51 (1.09–2.09) 0.16 1.23 (0.95–1.59) A 0.016 0.34 1.33 (1.09–1.63)
IL8 rs4694178 5.2E−05 1.26 (1.12–1.42) 0.064 1.13 (1.04–1.23) C 0.00040 0.0084 1.17 (1.10–1.26)
NRP1 rs734187 0.67 1.03 (0.90–1.18) 0.66 1.01 (0.92–1.12) A 0.56 1.0 1.02 (0.94–1.10)
NRP1 rs1331314 0.32 1.11 (0.92–1.34) 0.11 1.11 (0.97–1.26) G 0.061 1.0 1.11 (1.00–1.23)
NRP1 rs2073320 0.42 1.05 (0.93–1.18) 0.61 0.98 (0.90–1.06) NA 0.94 1.0 1.00 (0.94–1.07)
TRAF6 rs5030482 0.0094 1.25 (1.05–1.49) 0.12 1.10 (0.97–1.24) T 0.0097 0.20 1.14 (1.03–1.26)
TRAF6 rs5030472 0.013 1.28 (1.05–1.55) 0.19 1.09 (0.96–1.25) C 0.020 0.42 1.15 (1.03–1.28)
STAT5B rs6503691 0.44 1.08 (0.88–1.32) 0.78 0.98 (0.86–1.12) NA 0.91 1.0 1.01 (0.90–1.13)
PIAS4 rs2289863 0.19 1.09 (0.96–1.25) 0.72 0.98 (0.89–1.08) NA 0.76 1.0 1.02 (0.95–1.10)

Abbreviations: CI, confidence Interval; MAF, minor Allele Frequency; NA, not Available; OR, odds ratio; SNP, single-nucleotide polymorphism.

a

826 Swedish cases and 1835 controls genotyped in the discovery and replication phases including controls genotyped on the 1M chip.

b

1310 US SLE cases and 7859 controls genotyped in a GWAS. Genotypes for rs17433930, rs3754974, rs2030171, rs16833172, rs4694178, rs734187, rs1331314 and rs5030482 were imputed in this dataset as described in Gateva et al.

c

Meta-analysis including 2136 SLE cases and 9694 controls.

d

P-values calculated using SNPtest.

e

Odds ratios are calculated relative to the risk allele defined in the analysis of the combined Swedish cohort.

f

P-value corrected for the 21 tested SNPs.

P-values <0.05 are indicated in bold.